Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Clinical Results in Heavily Pre-Treated, Drug Refractory Hematologic Malignancies Using Chemotherapy and Targeted Agents Selected By Ex Vivo Analysis of Programmed Cell Death (EVA/PCD)

Vinicius Renan Pinto Mattos, MD, Nelson Hamerschlak, MD PhD, Isabel Nagle Reis, MD, Dirceu Hamilton Cordeiro Campelo, MD, Michelle Petrolli Silveira, MD, Flavia Munhoz Ferreira, MD, Juliano Cordova Vargas, MD, Paulo Vidal Campregher, MD, Fabio P.S. Santos, MD, Fabio R. Kerbauy, MD PhD, Joao C. C. Guerra, MD PhD, Claudio Galvão Castro Júnior, MD, Steven S. Evans, MS, Robert Nagourney, MD

Blood (2015) 126 (23): 3249.

https://doi.org/10.1182/blood.V126.23.3249.3249

Published: 2015

Journal Articles

Myelodysplastic Syndrome with Fibrosis: Experience of a Single-Institution with 139 Patients.

Fabio P.S. Santos, MD, Ellen Schlette, MD, Hagop Kantarjian, MD, Rachel Sargent, Guillermo Garcia-Manero, MD, Srdan Verstovsek, MD, PhD, Tapan Kadia, MD, Elias Jabbour, MD, Sherry Pierce, Gautam Borthakur, MD

Blood (2009) 114 (22): 2775.

https://doi.org/10.1182/blood.V114.22.2775.2775

Published: 2009

Journal Articles

Prognostic Impact of CD20 and CD25 Expression in Patients with Philadelphia-Positive (Ph + ) Acute Lymphoblastic Leukemia (ALL).

Fabio P.S. Santos, MD, Susan O'Brien, MD, Deborah A. Thomas, MD, Jorge Cortes, MD, Stefan Faderl, MD, Jeffrey L. Jorgensen, MD, PhD, Rebecca Garris, Charles Koller, MD, Partow Kebriaei, MD, Alessandra Ferrajoli, MD, Hagop Kantarjian, MD, Farhad Ravandi, MD

Blood (2009) 114 (22): 984.

https://doi.org/10.1182/blood.V114.22.984.984

Published: 2009

Journal Articles

Acute Erythroleukemia: An Analysis of 108 Patients Treated with Cytarabine-Containing Regimens at the M.D. Anderson Cancer Center.

Fabio P.S. Santos, MD, Stefan Faderl, MD, Guillermo Garcia-Manero, MD, Charles A. Koller, MD, Miloslav Beran, MD, PhD, Gautam Borthakur, MD, Carlos Bueso-Ramos, MD, PhD, Michael Keating, MB, BS, Jorge Cortes, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD

Blood (2008) 112 (11): 925.

https://doi.org/10.1182/blood.V112.11.925.925

Published: 2008

Journal Articles

Clinical Significance of Dose Reductions of Second-Generation Tyrosine Kinase Inhibitors (TKI) in Patients (Pts) with Chronic Myeloid Leukemia (CML)

Fabio P.S. Santos, MD, Hagop Kantarjian, MD, Carmen Fava, MD, Susan O’Brien, MD, Guillermo Garcia-Manero, MD, Steven Kornblau, MD, Farhad Ravandi, MD, William Wierda, MD, PhD, Jorge Cortes, MD

Blood (2008) 112 (11): 3217.

https://doi.org/10.1182/blood.V112.11.3217.3217

Published: 2008

NARROW

Clinical Results in Heavily Pre-Treated, Drug Refractory Hematologic Malignancies Using Chemotherapy and Targeted Agents Selected By Ex Vivo Analysis of Programmed Cell Death (EVA/PCD)

Myelodysplastic Syndrome with Fibrosis: Experience of a Single-Institution with 139 Patients.

Prognostic Impact of CD20 and CD25 Expression in Patients with Philadelphia-Positive (Ph + ) Acute Lymphoblastic Leukemia (ALL).

Acute Erythroleukemia: An Analysis of 108 Patients Treated with Cytarabine-Containing Regimens at the M.D. Anderson Cancer Center.

Clinical Significance of Dose Reductions of Second-Generation Tyrosine Kinase Inhibitors (TKI) in Patients (Pts) with Chronic Myeloid Leukemia (CML)

Email alerts

ASH Publications

American Society of Hematology

Clinical Results in Heavily Pre-Treated, Drug Refractory Hematologic Malignancies Using Chemotherapy and Targeted Agents Selected By Ex Vivo Analysis of Programmed Cell Death (EVA/PCD)

Myelodysplastic Syndrome with Fibrosis: Experience of a Single-Institution with 139 Patients.

Prognostic Impact of CD20 and CD25 Expression in Patients with Philadelphia-Positive (Ph + ) Acute Lymphoblastic Leukemia (ALL).

Acute Erythroleukemia: An Analysis of 108 Patients Treated with Cytarabine-Containing Regimens at the M.D. Anderson Cancer Center.

Clinical Significance of Dose Reductions of Second-Generation Tyrosine Kinase Inhibitors (TKI) in Patients (Pts) with Chronic Myeloid Leukemia (CML)

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only